2,4-Difluorobenzylamine (CAS: 72235-52-0) is an important aromatic fluorinated organic amine compound with the chemical formula C₇H₇F₂N, appearing as a colorless to pale yellow transparent liquid. The unique difluorobenzyl group and reactive amino site in its molecular structure endow it with excellent reactivity and biocompatibility, making it a core structural unit for constructing a variety of high-value pharmaceutical and pesticide molecules. This special chemical property grants it irreplaceable strategic value in the fields of anti-HIV and other antiviral drugs, new high-efficiency pesticides, and fine organic synthesis. Its production is highly dependent on professional fluorinated fine chemical synthesis processes, and the market demand is closely linked to the global trends of innovative drug R&D, generic drug volume expansion and green pesticide upgrading. Based on the industrial attributes and application characteristics of this compound, this paper systematically analyzes its global market dynamics, focusing on core application scenarios, key synthesis process points, regulatory compliance requirements and future trends, so as to provide strategic reference for industry participants.
(I) Core Application Fields, Characteristics and Synthesis Processes
The market demand for 2,4-difluorobenzylamine(CAS: 72235-52-0) is highly concentrated in three major fields: pharmaceutical raw materials, pesticide creation and fine organic synthesis intermediates. The unique difluoro-substituted structure and highly reactive amino group in its molecule are the core advantages supporting its high added value and driving demand growth.
Core Characteristics
Excellent biological activity: The introduction of two fluorine atoms significantly improves the lipophilicity, metabolic stability and targeted binding ability of the compound, making it a key structural unit for constructing antiviral, antibacterial and high-efficiency pesticide molecules.
Outstanding reactivity: As an aromatic primary amine, its amino group can efficiently participate in amidation, condensation, cyclization and other reactions with strong compatibility and clear conversion paths, serving as an extremely commonly used key building block in laboratory and industrial synthesis.
Obvious process barriers: The product has stringent requirements for purity, moisture, free fluorine and color index. In particular, the pharmaceutical grade needs strict control of impurity residues, which directly determines the quality and safety of downstream drugs.
Synthesis Processes
At present, chemical synthesis is the main industrial method. The mainstream processes use 2,4-difluorobenzaldehyde or 2,4-difluorobenzyl chloride as starting materials, which are prepared through amination, reduction and distillation purification. Large-scale production generally adopts catalytic hydrogenation reduction and continuous ammonolysis processes, which have the advantages of high yield, less three wastes and controllable cost. Due to the product’s susceptibility to moisture absorption and oxidation, and the extremely high purity requirement for pharmaceutical grade (usually ≥99.5%), the entire production process must be carried out under anhydrous and oxygen-free conditions, closed distillation and inert gas protection, and the finished product must be stored at low temperature, sealed and moisture-proof.
(II) Product Market Pattern and Regional Characteristics
The global market of 2,4-difluorobenzylamine(CAS: 72235-52-0) presents a pattern of “oligopoly dominance and clear regional division of labor”, with the industry concentration continuously improving. The core competition focuses on high-purity pharmaceutical grade products. Regional characteristics are deeply bound to the downstream demand structure, and the supply and demand distribution shows significant differentiation.
In terms of market pattern, the world’s top five enterprises account for 62.8% of the market share, forming an oligopolistic competition pattern. Among them, multinational enterprises such as Basel in Switzerland, Bayer in Germany and DuPont in the United States dominate the high-end market. Relying on compliance certification and technical advantages, they focus on the supply of high-purity pharmaceutical grade products and occupy the core demand market in Europe and the United States. Chinese enterprises take the leading position in the mid-to-high-end market with the advantage of production capacity scale. Ltd. have emerged to seize the segmented market with the advantages of customized services and regional logistics. Small and medium-sized enterprises focus on pesticide grade and industrial grade products, participating in low-end market competition by virtue of cost advantages, and the industry integration is advancing continuously.
In terms of regional characteristics, the European, American and Japanese markets are dominated by high-end demand, with core consumption concentrated in the R&D of anti-HIV drugs and high-efficiency pesticides, emphasizing impurity control and compliance certification, and being the core consumption areas for high-value-added products. Only a few Chinese enterprises have entered this market through certification.
China and the Asia-Pacific market are the world’s major production bases and growth engines. In 2024, China’s production capacity accounted for 72.6% of the global total, and the production capacity in East China accounted for 54.8% of the domestic total, which not only meets the domestic demand for pharmaceutical generic drugs and pesticide creation, but also exports a large number of products to Europe and the United States, with exports accounting for 59.2% of domestic output. The demand in emerging markets such as the Middle East and South America is gradually releasing, mainly for pesticide grade products, which has become a potential growth space for small and medium-sized enterprises. Regional logistics and cost control are the core competitive factors..
(III) Regulatory, Environmental and Safety Considerations
As a key fluorinated intermediate widely used in the pharmaceutical and pesticide fields, the production, trade and use of 2,4-difluorobenzylamine are subject to strict regulatory requirements in the world’s major markets, focusing on product purity, impurity control and application compliance.
In the US market, as a pharmaceutical intermediate, it must comply with the relevant FDA regulations for pharmaceutical raw materials, provide impurity profile, purity test reports and production process compliance certificates. When used in the production of anti-HIV and other drugs, it must pass the CGMP (Current Good Manufacturing Practice) certification. At the same time, as a chemical raw material, it must comply with the occupational exposure limit requirements of OSHA (Occupational Safety and Health Administration).
In the EU market, it must meet the REACH regulation registration requirements. Enterprises with an import volume of more than 1 ton must complete the screening and registration of Substances of Very High Concern (SVHC). When used in the pharmaceutical field, it must comply with the raw material standards of EDQM (European Directorate for the Quality of Medicines & HealthCare) to ensure that impurity residues meet the pharmaceutical grade requirements. Enterprises must strictly control product indicators such as purity and free fluorine content to meet the restrictions on the scope of use.
In other markets, manufacturers and exporters must refer to the relevant regulations on pharmaceutical raw materials and pesticide intermediates of the target countries for compliance declaration. For example, China must comply with the Good Manufacturing Practice for Pharmaceutical Products and Safety Renovation Standards for Fine Chemical Enterprises, while emerging markets such as India and Brazil must meet the local import inspection standards for pharmaceutical raw materials.
Health Hazards
According to safety data, this substance is irritating and corrosive to the eyes, skin and respiratory tract, and may cause skin allergies with long-term contact. It has moderate oral toxicity (LD50 for rats by oral administration is 1000-2000 mg/kg), and proper protection must be taken during operation.
Physical Hazards
With a flash point of about 78℃, it is a flammable liquid that is easy to burn when exposed to open fire and high temperature, and may react when in contact with strong acids and oxidants.
Storage and Transportation Requirements
Due to its susceptibility to moisture absorption and oxidation, commercial products are usually required to be stored in a sealed, dry, cool and ventilated place. Pharmaceutical grade products need to be protected by inert gas to avoid damp and deterioration. Corrosion-resistant containers must be used for bulk transportation. International trade must comply with the UN3259 dangerous goods transportation rules, with compliant packaging and warning marks.
Environmental Aspects
As a fluorinated fine chemical product, the treatment of fluorinated wastewater, solvent volatilization and by-products in its production process is the core focus of environmental protection. Fluorinated wastewater must be treated to meet the standard before discharge to avoid water pollution. Leading enterprises are committed to optimizing catalytic hydrogenation and continuous synthesis processes, promoting solvent recovery technologies, and reducing VOCs emissions and fluorinated waste generation to lower environmental impacts.
(IV) Future Outlook
The market prospect of 2,4-difluorobenzylamine(CAS: 72235-52-0) is deeply bound to the three global trends of pharmaceutical innovation, domestic localization of patented drugs and regionalization of supply chains.
Pharmaceutical R&D and Innovation
Fluorinated organic intermediates have significant advantages in new drug design, which can enhance drug metabolic stability and membrane permeability. As a key structural unit, 2,4-difluorobenzylamine is widely used in the R&D of new drugs such as antiviral and antitumor drugs.
Domestic Localization of Patented Drugs
With the expiration of patents for integrase inhibitors such as dolutegravir and the promotion of national volume-based procurement policies, the market demand for it as a core intermediate continues to expand.
Supply Chain Regionalization
Under the background of the restructuring of the global industrial chain, downstream preparation enterprises are more inclined to cultivate stable and high-quality nearshore and onshore suppliers, bringing a window of opportunity for Chinese enterprises.
Major Industry Challenges
International trade barriers: The escalation of US tariff policies has led Chinese 2,4-difluorobenzylamine enterprises to face challenges such as a sharp increase in export costs and restricted market access.
Storage and transportation safety requirements: As an amine corrosive dangerous chemical (UN 2735), it is sensitive to air and acidic media, requiring inert gas protection for storage and high requirements for transportation packaging, which increases the whole-chain operation costs.
Environmental regulatory pressure: The fine chemical production process is facing increasingly stringent environmental regulations, putting forward higher requirements for enterprises’ green production processes and three wastes treatment capabilities.
Response Strategies
Enterprises need to focus on three major directions:
Technical level: Continuously optimize synthesis and purification processes to ensure the stable supply of high-purity products above 99%; study inherently safe processes such as continuous flow reactions to reduce production risks; expand its application in a wider range of fine chemical fields such as pesticides, dyes and new materials.
Supply chain and compliance level: Faced with international trade frictions, actively implement distributed layout models such as “regional manufacturing hubs” and diversify risks through market diversification (e.g., Southeast Asia, Central and Eastern Europe). At the same time, build a sound hazardous chemical storage and transportation management system and compliance information database to quickly respond to regulatory requirements in different regions.
Application level: Strengthen in-depth cooperation with downstream pharmaceutical companies and CDMO enterprises to provide customized and compliant intermediate solutions from laboratory R&D to commercial production, rather than just selling raw materials.
Conclusion
As a high-value-added fluorinated fine chemical intermediate, the core value of 2,4-difluorobenzylamine lies in serving as a key building unit in the upper reaches of the pharmaceutical industry chain to support the synthesis and implementation of downstream innovative drugs. Despite facing international trade frictions and strict storage and transportation requirements, driven by global pharmaceutical innovation and the upgrading of China’s generic drug industry, its market demand has strong resilience. In the future, enterprises with exquisite synthesis and purification technologies, global compliance service capabilities and supply chain risk dispersion capabilities will be better able to capture the growth opportunities in this segmented market.
(V) In-depth Analysis of the Domestic Chinese Market
Market Pattern and Core Drivers
China is one of the world’s most important production bases for 2,4-difluorobenzylamine, and the market presents a significant characteristic of “high concentration and single-core drive”.. The demand side is extremely dependent on the pharmaceutical intermediate field, especially the domestic volume expansion of the anti-AIDS drug dolutegravir, which constitutes the core engine of market growth. With the expiration of original drug patents and the in-depth advancement of national volume-based procurement policies, the demand of downstream preparation enterprises for high-quality and stably supplied local intermediates continues to rise.
Competitive Ecology and Price Trends
The industry competition pattern is relatively stable, and new entrants face high technical, environmental and customer certification barriers. At present, the market supply and demand are basically balanced, and the price system is transparent. According to market monitoring data, since the middle of 2025, the domestic market quotation of 2,4-difluorobenzylamine has been stable at about 300 CNY per kilogram, showing strong price resilience. The mainstream product specification is 99% purity, meeting the stringent requirements of pharmaceutical synthesis.
Challenges and Prospect Outlook
The development of the industry is facing dual tests: first, as a dangerous chemical, strict storage and transportation safety and environmental regulatory requirements have pushed up operating costs; second, the single downstream application field leads to the need to improve the market’s anti-risk capability. In the future, the growth points of the domestic market will focus on the in-depth expansion of the existing pharmaceutical industry chain, while actively extending horizontally to fine chemical fields such as pesticides and new materials. Enterprises with exquisite synthesis processes, large-scale production capacity and strong compliance qualifications will continue to consolidate their leading position in stock competition and incremental expansion.
(VI) Reasons to Choose Shanghai Xianchen Chemical Co., Ltd.
Relying on its profound accumulation in the field of organic synthesis and fine chemicals, Shanghai Xianchen Chemical Co., Ltd. (XinChem) provides customers with one-stop high-value solutions:
Technical Advantages: Specialized processes ensure high purity and activity with controllable isomer ratio.
Supply Chain Advantages: GMP production lines support the smooth delivery of scientific research samples to large-scale orders.
Service Advantages: An experienced team provides application consulting, process optimization and safety guidance.
Sustainability and Safety: Green processes, solvent recovery and strict storage and transportation management comply with international standards.
Choosing Shanghai Xianchen Chemical Co., Ltd. enables you to obtain high-quality raw materials, stable supply, technical services and compliance guarantees, helping the innovation and industrial upgrading of high-end chemicals, functional materials and fine chemical applications.
Contact Us Now to Start Cooperation!
Official Website: www.xinchem.com
Email: sales1@xinchem.com
WhatsApp: +86 18049800532
Post time: Mar-06-2026